SCHEMBL3370657

SCHEMBL3370657

Cc1cc(N)ccc1Oc1ccnc(C#N)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.44
FEN1 P39748 3/20 0.44
GAA P10253 1/20 0.41
LRRK2 Q5S007 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
USP2 O75604 1/20 0.39
SCN5A Q14524 1/20 0.39
SCN9A Q15858 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
AR P10275 5/20 0.38
POLB P06746 1/20 0.35
KDR P35968 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6388264 0.85 KDM4E (0.48) ALOX5APFEN1GAAKDM4EALDH1A1
SCHEMBL1642817 0.83 ALOX5AP (0.52) ALOX5APFEN1KDM4EALDH1A1USP2
SCHEMBL5569494 0.82 KDM4E (0.40) ALOX5APFEN1GAALRRK2KDM4E
SCHEMBL4800469 0.81 SCN5A (0.40) GAAKDM4EALDH1A1SCN5ASCN9A
SCHEMBL4325879 0.81 NOS3 (0.51) ALOX5APFEN1GAAKDM4EALDH1A1
SCHEMBL1642799 0.81 ALDH1A1 (0.48) ALOX5APFEN1GAAALDH1A1SCN5A
SCHEMBL15044498 0.78 AAK1 (0.38) ALOX5APFEN1KDM4EALDH1A1SCN5A
SCHEMBL2028930 0.78 SCN9A (0.43) KDM4EALDH1A1SCN5ASCN9AMEN1
SCHEMBL3366823 0.78 ALOX5AP (0.41) ALOX5APFEN1KDM4EALDH1A1SCN5A
SCHEMBL30127305 0.78 ALDH1A1 (0.42) GAAKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599467-B1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER HEALTHCARE LLC (US) 2010-05-19 EP disclosed
EP-1599467-B1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER HEALTHCARE LLC (US) 2010-05-19 EP disclosed
EP-1599467-A1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-11-30 EP disclosed
WO-2004078747-A1 NOVEL CYANOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-09-16 WO disclosed